trending Market Intelligence /marketintelligence/en/news-insights/trending/d3foth1mukoobn-bd6mzjg2 content esgSubNav
In This List

Acerus Pharmaceuticals names CEO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Acerus Pharmaceuticals names CEO

Acerus Pharmaceuticals Corp. appointed Edward Gudaitis as president and CEO, effective May 1.

Luc Mainville will continue to act as interim CEO of the company and work with Gudaitis to ensure a smooth transition.

Following the transition, Mainville will resume his position as a board member.

Gudaitis most recently served as vice president and general manager of Allergan PLC's Allergan Canada.